{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:30:07Z","timestamp":1786721407346,"version":"build-2736575974"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>In recent years, continuous advances in interventional therapies for pulmonary diseases have made minimally invasive treatment an important focus of this field because of its limited trauma, rapid recovery, and reliable efficacy. As a representative minimally invasive modality, cryoablation kills tumor cells mainly through cold-induced cellular injury, vascular injury, and immune modulation. Although existing studies have confirmed the immune-activating effects of cryoablation, cryoablation alone is limited by insufficient antitumor immune intensity and restricted control of distant tumors, making it difficult to maximize systemic antitumor efficacy. Recent evidence suggests that combining cryoablation with immunotherapy may amplify antitumor effects through complementary mechanisms. However, unlike previous reviews that have focused primarily on general mechanisms and preliminary efficacy, few have delved into the translational bottlenecks of cryoablation parameters, treatment sequencing, and lymph-node management. In addition to summarizing the immunological mechanisms, research progress, clinical applications, and current challenges, this review goes beyond mere description by synthesizing evidence on these three underappreciated aspects, proposing a practical sequencing framework, and outlining actionable strategies for lymph-node preservation versus ablation. We further appraise the evidence tumor by tumor and grade it by evidence tier, so that the strength of every recommendation is explicit and the tumor types for which no clinical data exist are named. Together these elements offer a clearer and more clinically instructive perspective for combination immunotherapy and provide a theoretical basis for optimizing treatment strategies for patients with tumors.<\/jats:p>","DOI":"10.3389\/fonc.2026.1900725","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:39:51Z","timestamp":1786718391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cryoablation combined with immunotherapy: new strategies and progress in the treatment of tumors"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuxin","family":"Xiang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College","place":["Chengdu, China"]},{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]},{"name":"Key Laboratory of Geriatric Respiratory Diseases of Sichuan Higher Education Institutes","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College","place":["Chengdu, China"]},{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]},{"name":"Key Laboratory of Geriatric Respiratory Diseases of Sichuan Higher Education Institutes","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu Medical College","place":["Chengdu, China"]},{"name":"Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]},{"name":"Key Laboratory of Geriatric Respiratory Diseases of Sichuan Higher Education Institutes","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12247665","article-title":"From conversion to resection for unresectable hepatocellular carcinoma: a review of the latest strategies","volume":"12","author":"Liang","year":"2023","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cireng.2025.800197","article-title":"Surgical approach and postoperative outcomes after left pancreatectomy: the Spandispan prospective project","volume":"103","author":"Hern\u00e1ndez-Roca","year":"2025","journal-title":"Cir Esp (Engl Ed)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1574884711666161201123439","article-title":"The combination of new immunotherapy and radiotherapy: a new potential treatment for locally advanced non-small cell lung cancer","volume":"12","author":"Sacco","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27962","article-title":"Treatment modalities and risks of complication for patients with localized renal cell carcinoma aged 75 and older","volume":"131","author":"Suk-Ouichai","year":"2025","journal-title":"J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.06.019","article-title":"Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study)","volume":"39","author":"Kodama","year":"2021","journal-title":"Urol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cryobiol.2013.11.001","article-title":"Mechanisms of cryoablation: clinical consequences","volume":"68","author":"Baust","year":"2014","journal-title":"Cryobiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"107871","DOI":"10.1016\/j.jvir.2025.10.004","article-title":"Cryoablation protocols for primary and metastatic lung tumors: a systematic review and meta-analysis evaluating effectiveness and safety of percutaneous cryoablation of pulmonary tumors","volume":"37","author":"Sarshoghi","year":"2026","journal-title":"J Vasc Interv Radiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1323070","article-title":"Modern cancer therapy: cryoablation meets immune checkpoint blockade","volume":"14","author":"Liu","year":"2024","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0371","article-title":"Cryoablation does not significantly contribute to systemic effector immune responses in a poorly immunogenic B16F10 melanoma model","volume":"30","author":"Yakkala","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8927-x","article-title":"Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer","volume":"65","author":"Lin","year":"2017","journal-title":"Immunol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1975.tb00073.x","article-title":"Alternate cryogens for cryosurgery","volume":"1","author":"Torre","year":"1975","journal-title":"J Dermatol Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","article-title":"Integrative proteomic characterization of human lung adenocarcinoma","volume":"182","author":"Xu","year":"2020","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1006\/cryo.1998.2115","article-title":"Mechanisms of tissue injury in cryosurgery","volume":"37","author":"Gage","year":"1998","journal-title":"Cryobiology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1055\/a-0598-5134","article-title":"Current technique and application of percutaneous cryotherapy","volume":"190","author":"Mahnken","year":"2018","journal-title":"Rofo"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(97)90082-9","article-title":"Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model","volume":"122","author":"Weber","year":"1997","journal-title":"Surgery"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13111114","article-title":"In situ vaccination by tumor ablation: principles and prospects for systemic antitumor immunity","volume":"13","author":"Chikovani","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.1891","article-title":"Association between duration of immunotherapy and overall survival in advanced non-small cell lung cancer","volume":"9","author":"Sun","year":"2023","journal-title":"JAMA Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40425-018-0468-x","article-title":"Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy","volume":"6","author":"Adam","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03883-5","article-title":"First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial","volume":"31","author":"Hong","year":"2025","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70250","article-title":"Sacituzumab tirumotecan improved survival for patients with EGFR TKI-resistant, EGFR-mutant advanced NSCLC","volume":"132","author":"Lawrence","year":"2026","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c05809","article-title":"Cryo-nanocatalyst enhances therapeutic efficacy of cryo-immunotherapy through necroptosis and local delivery of programmed death-ligand 1 inhibitors","volume":"18","author":"Lee","year":"2024","journal-title":"ACS Nano"},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2079-1","article-title":"A bioorthogonal system reveals antitumour immune function of pyroptosis","volume":"579","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.695150","article-title":"Rate of freeze impacts the survival and immune responses post cryoablation of melanoma","volume":"12","author":"Yakkala","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2024.2415365","article-title":"Cryoablation plus chemotherapy regimen enhance anti-tumor immune response in a mouse model of Lewis lung cancer","volume":"41","author":"Duan","year":"2024","journal-title":"Int J Hyperthermia"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1352","article-title":"PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor","volume":"22","author":"Shi","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.223","article-title":"Immune parameters affecting the efficacy of chemotherapeutic regimens","volume":"8","author":"Zitvogel","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/35074122","article-title":"IFN-gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-gamma: teammate or opponent in the tumour microenvironment","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo5409","article-title":"Interleukin-2-based therapies in cancer","volume":"14","author":"Raeber","year":"2022","journal-title":"Sci Transl Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.930461","article-title":"Cryoablation reshapes the immune microenvironment in the distal tumor and enhances antitumor immunity","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008386","article-title":"Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer","volume":"12","author":"Gu","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202521931","article-title":"Cryoablation activates the cGAS-STING-CXCL10 axis in macrophages to enhance anti-tumor immunity in NSCLC","volume":"13","author":"Zhi","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12916-025-03926-1","article-title":"Cryoablation-induced modulation of Treg cells and the TGF-beta pathway in lung adenocarcinoma: implications for increased antitumor immunity","volume":"23","author":"Lin","year":"2025","journal-title":"BMC Med"},{"key":"B38","first-page":"395","article-title":"Studies in cryo-immunology. I. The production of antibodies to urogenital tissue in consequence of freezing treatment","volume":"12","author":"Yantorno","year":"1967","journal-title":"Immunology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/0011-2240(71)90050-2","article-title":"Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate","volume":"8","author":"Ablin","year":"1971","journal-title":"Cryobiology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0011-2240(82)90151-1","article-title":"Immunological aspects of cryosurgery in general surgery","volume":"19","author":"Tanaka","year":"1982","journal-title":"Cryobiology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1840","article-title":"Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation","volume":"12","author":"Udagawa","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-014-1520-4","article-title":"Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant elicits a specific antitumor immunity","volume":"63","author":"Alteber","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","article-title":"Immune therapy for cancer","volume":"27","author":"Dougan","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1782","article-title":"Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy","volume":"72","author":"Waitz","year":"2012","journal-title":"Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2020.09.014","article-title":"Thermal ablation, embolization, and selective internal radiation therapy combined with checkpoint inhibitor cancer immunotherapy: safety analysis","volume":"32","author":"Leppelmann","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071681","article-title":"Dual effect of immune cells within tumour microenvironment: pro-and anti-tumour effects and their triggers","volume":"14","author":"Pena-Romero","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445513","article-title":"Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cryobiol.2019.01.015","article-title":"PD-1 blockade enhances the anti-tumor immune response induced by cryoablation in a murine model of renal cell carcinoma","volume":"87","author":"Zhu","year":"2019","journal-title":"Cryobiology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02566-z","article-title":"Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study","volume":"69","author":"Shen","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41392-025-02460-z","article-title":"Ablation plus immunotherapy versus immunotherapy alone in patients of advanced NSCLC who develop oligo-residual disease after anti-PD-1\/L1 therapy (BOOSTER): a randomized phase 2 trial","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050981","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"16","author":"Hato","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3182965dde","article-title":"Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer","volume":"42","author":"Niu","year":"2013","journal-title":"Pancreas"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.617365","article-title":"Immune modulation plus tumor ablation: adjuvants and antibodies to prime and boost anti-tumor immunity in situ","volume":"12","author":"van den Bijgaart","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.12659\/msm.898194","article-title":"The application of cytidyl guanosyl oligodeoxynucleotide can affect the antitumor immune response induced by a combined protocol of cryoablation and dendritic cells in Lewis lung cancer model","volume":"22","author":"Zhang","year":"2016","journal-title":"Med Sci Monit"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700777","article-title":"Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions","volume":"127","author":"Redondo","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1049802","article-title":"Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer","volume":"5","author":"Chandra","year":"2016","journal-title":"Oncoimmunology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1039\/D3MH00092C","article-title":"Autologous-cancer cryoablation-mediated nanovaccine augments systematic immunotherapy","volume":"10","author":"Yu","year":"2023","journal-title":"Mater Horiz"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c00941","article-title":"Liquid metal nanoplatform based autologous cancer vaccines","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"B65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejca.2016.04.013","article-title":"Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity","volume":"62","author":"Kudo-Saito","year":"2016","journal-title":"Eur J Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nature25492","article-title":"TGF-\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2024.100737","article-title":"CRYOVATE: a pilot study of lung cancer cryoactivation in combination with immunotherapy in advanced NSCLC","volume":"5","author":"Desilets","year":"2024","journal-title":"JTO Clin Res Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2025.44215","article-title":"Efficacy of argon-helium cryoablation combined with PD-1 inhibitors in non-small cell lung cancer","volume":"64","author":"Zheng","year":"2025","journal-title":"Acta Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s43018-025-01058-2","article-title":"Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial","volume":"7","author":"Gu","year":"2026","journal-title":"Nat Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17804","article-title":"Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i22.3473","article-title":"Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer","volume":"19","author":"Niu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023621","article-title":"Upregulation of circulating PD-L1\/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma","volume":"6","author":"Zeng","year":"2011","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1038\/s41467-024-51722-x","article-title":"Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial","volume":"15","author":"Mooradian","year":"2024","journal-title":"Nat Commun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00262-024-03637-1","article-title":"Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma","volume":"73","author":"Shen","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/sj.bjc.6603341","article-title":"Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity","volume":"95","author":"den Brok","year":"2006","journal-title":"Br J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0035-z","article-title":"Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer","volume":"21","author":"Benzon","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-019-0176-8","article-title":"A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer","volume":"23","author":"Ross","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03421-7","article-title":"A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer","volume":"72","author":"Thomsen","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B81","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/CJI.0b013e31818df785","article-title":"Combined cryoablation and GM-CSF treatment for metastatic hormone refractory prostate cancer","volume":"32","author":"Si","year":"2009","journal-title":"J Immunother"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00321-8","article-title":"Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial","volume":"24","author":"Barqawi","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1038\/s41467-021-26415-4","article-title":"Pilot study of tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma","volume":"12","author":"Campbell","year":"2021","journal-title":"Nat Commun"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1326441","article-title":"Characterization of the cryoablation-induced immune response in kidney cancer patients","volume":"6","author":"Kato","year":"2017","journal-title":"Oncoimmunology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12885-024-12596-w","article-title":"Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma","volume":"24","author":"Waidhauser","year":"2024","journal-title":"BMC Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0190","article-title":"A pilot study of preoperative single-dose ipilimumab and\/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling","volume":"22","author":"McArthur","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0013","article-title":"Deep sequencing of T-cell receptor DNA as a biomarker of clonally expanded tumor-infiltrating lymphocytes in breast cancer after immunotherapy","volume":"4","author":"Page","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108880","article-title":"Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer","volume":"27","author":"Comen","year":"2024","journal-title":"iScience"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-11157-w","article-title":"Tumor-infiltrating lymphocytes (TILs) as a biomarker of abscopal effect of cryoablation in breast cancer: a pilot study","volume":"29","author":"Khan","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1498942","article-title":"Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor Immune Microenvironment) in distant tumors","volume":"15","author":"Sardela de Miranda","year":"2024","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0846-1","article-title":"Rate of freeze alters the immunologic response after cryoablation of breast cancer","volume":"17","author":"Sabel","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10549-004-3289-1","article-title":"Immunologic response to cryoablation of breast cancer","volume":"90","author":"Sabel","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16181-0","article-title":"Cryoablation without excision for early-stage breast cancer: ICE3 trial 5-year follow-up on ipsilateral breast tumor recurrence","volume":"31","author":"Fine","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i12.113387","article-title":"Safety and efficacy of cryoablation in treating locally advanced pancreatic cancer","volume":"17","author":"Kang","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230187","article-title":"Evaluating the impact of adjunctive partial cryoablation on dual checkpoint inhibitor immunotherapy response in a murine model","volume":"6","author":"Wehrenberg-Klee","year":"2024","journal-title":"Radiol Imaging Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.250113","article-title":"Association between three-dimensional margin assessment and local tumor control in percutaneous lung cryoablation of colorectal metastases","volume":"8","author":"Mohn","year":"2026","journal-title":"Radiol Imaging Cancer"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2021.08.017","article-title":"Safety and feasibility of cryoablation during immunotherapy in patients with metastatic soft tissue sarcoma","volume":"32","author":"Doshi","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169445","article-title":"Tumor-specific immunoenhancing effects after local cryoablation for metastatic bone tumor in a mouse model","volume":"23","author":"Annen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejca.2020.10.035","article-title":"CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment","volume":"143","author":"Kurtz","year":"2021","journal-title":"Eur J Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0031-1278235","article-title":"Cryosurgery: a review","volume":"16","author":"Yiu","year":"2007","journal-title":"Int J Angiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1006\/cryo.1995.1021","article-title":"Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man","volume":"32","author":"Stewart","year":"1995","journal-title":"Cryobiology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0011-2240(02)00163-3","article-title":"Percutaneous cryoablation of colorectal liver metastases: potentiated by two consecutive freeze-thaw cycles","volume":"46","author":"Mala","year":"2003","journal-title":"Cryobiology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1858-x","article-title":"Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer","volume":"65","author":"Takahashi","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B104","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/13645700500468268","article-title":"Cryoablation of liver tumours: a review of mechanisms, techniques and clinical outcome","volume":"15","author":"Mala","year":"2006","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/153303460700600203","article-title":"Cryoablation of renal cancer: variables involved in freezing-induced cell death","volume":"6","author":"Clarke","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2012.48","article-title":"Temperature-dependent activation of differential apoptotic pathways during cryoablation in a human prostate cancer model","volume":"16","author":"Robilotto","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B107","article-title":"Changes in secretory function of Kupffer cells after freeze-thaw therapy for liver cancer","volume":"47","author":"Zhu","year":"2020","journal-title":"Cancer Res Prev Treat"},{"key":"B108","article-title":"A statistical model of the relationship between iceball and perfusion deficit visualized during MRI-guided cryoablation","author":"Dextraze","year":"2014","journal-title":"Radiol Soc North Am"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013074","article-title":"Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial","volume":"13","author":"Saad","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2009.12.403","article-title":"Cryoablation: mechanism of action and devices","volume":"21","author":"Erinjeri","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13244-019-0727-5","article-title":"Cryoablation and immunotherapy: an overview of evidence on its synergy","volume":"10","author":"Aarts","year":"2019","journal-title":"Insights Imaging"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1900725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:39:52Z","timestamp":1786718392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1900725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":114,"alternative-id":["10.3389\/fonc.2026.1900725"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1900725","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1900725"}}